SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
We are pleased to announce that Matt Golembeski has joined the team at SmartTRAK as Director of Sales. M...
COVID-19 hit the SCS market hard in Q220 as shutdowns and widespread procedure cancellations led to a dr...
Q220 brought unexpected strong demand for orthopedic robotics, despite the COVID-19 pandemic. Despite th...
Despite a downturn in the CAS spine market and a decrease in the proportion of robotic spine cases in Q2...
Calibrating the craziness and uncertainties of a roller coaster quarter Because Orthobiologics spans var...
With plans to become a stroke strategic, Imperative Care Chairman and CEO Fred Khosravi discusses elevat...
The effects of COVID-19 were felt throughout the WW Spine Market with dramatic Q220 declines in both the...
Q220 reflects the full impact of COVID-19, driving a downward slide in all segments For Q220, according ...
Mark Dickinson, Worldwide President of Cerenovus, discusses the Company’s focus on patients, innovation ...
Heavy-weight contender COVID-19 landed some brutal blows to revenue in Q220, but companies look for bett...
Login